11/10/2025
Big news for women in mid-life!
The FDA has announced it will remove the longstanding "black box" warning on many hormone-based therapies used to treat peri-menopause and menopause symptoms. It's a shift toward evidence-based, individualized care.
And excited to see Dr. Rachel Rubin on this episode, who I learned from during my Menopause Certification training, and who was instrumental in leading this change.
In an interview with CBS News, FDA Commissioner Dr. Marty Makary explains what went into the decision to drop the most serious warnings on hormone therapy for menopause.